These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32417351)

  • 1. Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy.
    Pasalic D; Ludmir EB; Allen PK; Thaker NG; Chapman BV; Hanna EY; Su SY; Ferrarotto R; Glisson BS; Reddy JP; Brandon Gunn G; Fuller CD; Phan J; Rosenthal DI; Morrison WH; Garden AS; Frank SJ
    Radiother Oncol; 2020 Jul; 148():258-266. PubMed ID: 32417351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.
    Zenda S; Kawashima M; Arahira S; Kohno R; Nishio T; Tahara M; Hayashi R; Akimoto T
    Int J Clin Oncol; 2015 Jun; 20(3):447-54. PubMed ID: 25135461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg.
    Bischoff M; Khalil DA; Frisch S; Bäcker CM; Peters S; Friedrich C; Tippelt S; Kortmann RD; Bison B; Müller HL; Timmermann B
    Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):137-148. PubMed ID: 38492813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.
    Lee HJ; Macomber MW; Spraker MB; Bowen SR; Hippe DS; Fung A; Russell KJ; Laramore GE; Rengan R; Liao J; Apisarnthanarax S; Zeng J
    Radiat Oncol; 2018 Sep; 13(1):179. PubMed ID: 30223877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry.
    Chhabra AM; Rice SR; Holtzman A; Choi JI; Hasan S; Press RH; Chang J; Halasz L; Tsai HK; Wang CJ; Kabolizadeh P; Gondi V; Hartsell WF; Vora SA; Vargas CE; Simone CB
    Radiother Oncol; 2023 Jun; 183():109551. PubMed ID: 36813169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    Verma V; Simone CB; Mishra MV
    J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
    Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.
    Fan M; Kang JJ; Lee A; Fan D; Wang H; Kitpanit S; Fox P; Sine K; Mah D; McBride SM; Tsai CJ; Riaz N; Dunn LA; Sherman EJ; Michel L; Singh B; Ganly I; Wong RJ; Boyle JO; Cohen MA; Lee NY
    Cancer; 2020 Jan; 126(9):1905-1916. PubMed ID: 32097507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial.
    Galland-Girodet S; Pashtan I; MacDonald SM; Ancukiewicz M; Hirsch AE; Kachnic LA; Specht M; Gadd M; Smith BL; Powell SN; Recht A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):493-500. PubMed ID: 24880212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes After Proton Beam Therapy for Sinonasal Squamous Cell Carcinoma.
    Russo AL; Adams JA; Weyman EA; Busse PM; Goldberg SI; Varvares M; Deschler DD; Lin DT; Delaney TF; Chan AW
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):368-376. PubMed ID: 27084654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry Study.
    Jazmati D; Steinmeier T; Ahamd Khalil D; Frisch S; Peters S; Schulze Schleithoff S; Bäumer C; Rutkowski S; Frühwald MC; Blase C; Tippelt S; Timmermann B
    Clin Oncol (R Coll Radiol); 2021 Jul; 33(7):e295-e304. PubMed ID: 33820696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
    Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
    Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
    Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
    Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton therapy for pediatric head and neck malignancies.
    Vogel J; Both S; Kirk M; Chao HH; Bagatell R; Li Y; Womer R; Balamuth N; Reilly A; Kurtz G; Lustig R; Tochner Z; Hill-Kayser C
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29058370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Sinonasal Cancer Treated With Proton Therapy.
    Dagan R; Bryant C; Li Z; Yeung D; Justice J; Dzieglewiski P; Werning J; Fernandes R; Pirgousis P; Lanza DC; Morris CG; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):377-385. PubMed ID: 27084655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
    Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
    Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.